Location: Home
  • search
  • go
  • Relate News
  • 7/26/2018SMIA: Urban and Rural Resident BMI Programs To Be Uniformed in 2019
  • 7/26/2018CNDA Releases List of Reference Formulations for Generic Drug Equivale...
  • 7/26/2018MSD Announces Chinese Approval of Its Blockbuster Anticancer Drug Keyt...
  • 7/26/2018China Presses Pharma Cos to Lower Anticancer Drug Prices As Prevalence...
  • 7/26/2018Ascletis Raises $400M in HK IPO
  • 7/26/2018Innovent Gets IND Clinical Approvals of Two Antibodies in China
  • 7/25/2018Betta Pharma to Reduce Price of Anticancer by 4% after Government Talk...
  • 7/25/2018WuXi STA's Jinshan API Plant Passes 4th U.S. FDA Inspection
  • 7/25/2018Sanofi Gets Chinese Approval of Its MS Drug Audagio
  • 7/24/2018Sinovant Sciences and Renexxion Form Partnership for Naronapride in Gr...
  • 7/24/2018Senior Executives of Scandalous Vaccine Maker Arrested by Police
  • 7/24/2018Bayer Wins Chinese Approval of Hemophilia A Drug
  • 7/24/2018CFDI to Initiate Clinical Data Inspection of 30 Drug Products (#20)
  • 7/24/2018CNDA Solicits Comments on Linked Evaluation and Approval of APIs, Exci...
  • 7/24/2018China To Establish More Intellectual Property Protection Centers
  • 7/24/2018XiAn Janssen's HIV Drug Prezcobix Approved in China
  • 7/24/2018Novartis Oncology Launches TPO-RA Agent Revolade in China
  • 7/24/2018The Diabetes Market in China
  • 7/24/2018SCMP: China's Vaccination System Has Been Crippled by Corruption, Weak...
  • 7/24/2018Tencent Licenses WebMD Contents for Provision thru WeChat
  • 7/24/2018BeiGene Reports Progress of Pivotal Trial for Anti-PD-1 Antibody in Ho...
  • 7/24/2018FT: Chinese Medical Tourism Exacerbates Shortage of HPV Vaccine
  • 7/23/2018Luye Pharma Gets Indication Expansion for AZ's CNS Drug
  • 7/23/2018Janssen's Yi Ke Granted Indication Expansion to CLL/ SLL in China
  • 7/23/2018Nicholas Hall Reports MAT Q1/2018 Data on the Global OTC / Chinese OTC...
  • 7/20/2018Laurel VC Acquires Global Rights of COPD Drug Candidate from Alpine IS
  • 7/20/2018Kolon Life Science Signs $203.5M Deal to Supply Invossa to Hainan
  • 7/20/2018CNDA Issues Guiding Principles for the Acceptance of Overseas Clinical...
  • 7/20/2018WuXi STA and Antengene Sign Development and Manufacturing Agreement
  • 7/20/2018Fosun Eyes Public Listing of Gland Pharma
  • Page:261/720 Total number of articles:21577: [First][<<] [259] [260] [261] [262] [263] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group